Hélène E. Aschmann

Author

Hélène E. Aschmann

Also Known As

Allan Musinguzi, Aschmann, Hélène E, H. Aschmann, H. E. Aschmann, Helene Aschmann, Helene E Aschmann, Hélène Aschmann, Hélène E Aschmann, Hélène E. Aschmann, Hélène Eloise Aschmann

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Zurich University of California, San Francisco University Hospital of Zurich Johns Hopkins University Boston University

About

Hélène E. Aschmann is an author at University of Zurich specializing in medicine, epidemiology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	222
2	Public Health	6	6	177
3	Business	1	1	16
4	Health Sciences	1	1	17
5	Biochemistry	1	1	22

Hélène E. Aschmann

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study Dominik Menges, Tala Ballouz, A Anagnostopoulos, PLoS ONE	2021	341
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study Tala Ballouz, Dominik Menges, A Anagnostopoulos, BMJ	2023	178
Burden of Post-COVID-19 Syndrome and Implications for Healthcare Service Planning: A Population-based Cohort Study Dominik Menges, Tala Ballouz, A Anagnostopoulos, Disease ManagementPopulation Health SciencesCovid-19 EpidemiologyCovid-19Social Health	2021	72
Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease Henock G. Yebyo, Hélène E. Aschmann, Milo A. Puhan Annals of Internal Medicine	2018	68
Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults Ariel R. Green, Hélène E. Aschmann, Cynthia M. Boyd, JAMA Network Open	2021	49
COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data Yea‐Hung Chen, Alicia R. Riley, Kate A. Duchowny, The Lancet Public Health	2022	43
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy Henrik Cordes, Christoph Thiel, Hélène E. Aschmann, Antimicrobial Agents and Chemotherapy	2016	40
Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US Ruijia Chen, Marie‐Laure Charpignon, Rafeya V. Raquib, JAMA Neurology	2023	36
Racial and Ethnic Disparities in Estimated Excess Mortality From External Causes in the US, March to December 2020 Ruijia Chen, Hélène E. Aschmann, Yea‐Hung Chen, JAMA Internal Medicine	2022	33
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort Dominik Menges, Kyra D. Zens, Tala Ballouz, Nature Communications	2022	31

Page 1